Secukinumab in Moderate to Severe Hidradenitis Suppurativa: Primary Endpoint Analysis From the SUNSHINE and SUNRISE Phase 3 Trials

SKIN The Journal of Cutaneous Medicine(2023)

Cited 1|Views16
No score
Key words
severe hidradenitis suppurativa,hidradenitis suppurativa
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined